Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director WRIGHT TIMOTHY R
Apr 1 21:43 ET
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Stein Robert Benjamin
Mar 29 21:33 ET
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Barrage Khalil
Mar 29 21:33 ET
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Buell Jennifer
Mar 29 21:33 ET
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer ARMEN GARO H
Mar 29 21:33 ET
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Corvese Brian
Mar 29 21:33 ET
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Arrow Alexander K.
Mar 29 21:33 ET
Protagenic Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(5.13%),Steven Boyd(5.13%)
Feb 14 15:28 ET
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Arrow Alexander K.
Oct 13, 2023 12:48 ET
Protagenic Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(5.26%),Steven Boyd(5.26%)
Feb 14, 2023 13:17 ET
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities
May 18, 2022 17:11 ET
Protagenic Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(5.4%),Steven Boyd(5.4%)
Feb 14, 2022 18:19 ET
Protagenic Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Hudson Bay Capital Management LP(0%),Sander Gerber(0%)
Feb 4, 2022 16:29 ET
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities
Jun 3, 2021 18:13 ET
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities
Jun 1, 2021 18:54 ET
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities
Jun 1, 2021 06:05 ET
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities
May 20, 2021 16:24 ET
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities
May 5, 2021 06:10 ET
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities
May 3, 2021 16:15 ET
Protagenic Therapeutics | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Feb 10, 2021 15:43 ET
No Data
No Data